Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4775559

O=C(Nc1ccc2c(c1)CCN(C1CCC1)CC2)c1ccc2occc2c1.O=C(O)C(F)(F)F

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 2/20 0.47
CHRNA7 P36544 5/20 0.43
HTR3A P46098 3/20 0.43
HTR3E A5X5Y0 1/20 0.43
HTR3B O95264 1/20 0.43
CYP2D6 P10635 1/20 0.43
HTR3D Q70Z44 1/20 0.43
HTR3C Q8WXA8 1/20 0.43
HRH3 Q9Y5N1 1/20 0.42
TRPV1 Q8NER1 1/20 0.41
NAMPT P43490 1/20 0.41
PLAU P00749 1/20 0.41
RAB9A P51151 4/20 0.41
NPC1 O15118 3/20 0.41
NFKB1 P19838 3/20 0.41
NFKB2 Q00653 3/20 0.41
RELA Q04206 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
TP53 P04637 2/20 0.41
HTT P42858 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4767916 0.85 TMPRSS2 (0.55) SLC2A1HRH3TRPV1PLAURAB9A
Trifluoroacetic Acid SCHEMBL4774281 0.83 SLC2A1 (0.58) SLC2A1HRH3TRPV1RAB9ANPC1
Trifluoroacetic Acid SCHEMBL4768268 0.82 SLC2A1 (0.47) SLC2A1CHRNA7HRH3TRPV1PLAU
Trifluoroacetic Acid SCHEMBL4767622 0.82 HRH3 (0.51) SLC2A1HRH3TRPV1PLAURAB9A
Trifluoroacetic Acid SCHEMBL4775284 0.82 NPC1 (0.52) SLC2A1RAB9ANPC1NFKB1NFKB2
Trifluoroacetic Acid SCHEMBL4770312 0.82 MAOB (0.49) SLC2A1RAB9ANPC1NFKB1NFKB2
Trifluoroacetic Acid SCHEMBL4768140 0.81 SLC2A1 (0.48) SLC2A1HRH3TRPV1PLAURAB9A
Trifluoroacetic Acid SCHEMBL4772660 0.81 ESR1 (0.50) SLC2A1CHRNA7HTR3AHRH3TRPV1
Trifluoroacetic Acid SCHEMBL4765505 0.81 SLC2A1 (0.50) SLC2A1HRH3TRPV1RAB9ANPC1
Trifluoroacetic Acid SCHEMBL4775421 0.80 KCNK3 (0.51) SLC2A1RAB9ANPC1NFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1713778-B1 BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS GLAXO GROUP LTD (GB) 2008-01-16 EP claimed
US-20070060566-A1 Benzazepine derivatives as histamine h3 antagonists GLAXO GROUP LIMITED (GB) 2007-03-15 US claimed
EP-1713778-B1 BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS GLAXO GROUP LTD (GB) 2008-01-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060566-A1 Benzazepine derivatives as histamine h3 antagonists HRH3, HRH4, HRH1 SLC2A1 4665/4885CHRNA7 55/4885HTR3A 34/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.